journal of men's health
Volume 6, Issue 1 , Pages 63-69 , March 2009

Serum lipids, uric acid and leptin/adiponectin ratio in clinically healthy normal weight and overweight young men, aged 17–20 years

  • Maria K. Todorova, MD, PhD

      Affiliations

    • Department of Pathophysiology, Medical University, Sofia, Bulgaria
    • Corresponding Author InformationCorresponding author.
    • ,
  • Zorka N. Ramsheva, MD

      Affiliations

    • Central Clinical Laboratory, Military Medical Academy, Sofia, Bulgaria
    • ,
  • Konstantin N. Ramshev, MD, PhD

      Affiliations

    • Department of Cardiology and Intensive Therapy, Military Medical Academy, Sofia, Bulgaria
    • ,
  • Marta P. Baleva, MD, DSci

      Affiliations

    • Clinic of Allergology, Alexandrov Hospital, Sofia, Bulgaria
    • ,
  • Zdravko A. Kamenov, MD, PhD

      Affiliations

    • Clinic of Endocrinology, Alexandrov Hospital, Sofia, Bulgaria
    • ,
  • Ljubomir S. Alexiev, MD, PhD

      Affiliations

    • Central Military Commision, Military Medical Academy, Sofia, Bulgaria

Received 27 May 2008 ,Accepted 3 September 2008.

References 

  1. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004;350(23):2362–2374
  2. Kim H, Park J, Kim H-S, Kim D, Park S. Obesity and cardiovascular risk factors in Korean children and adolescents aged 10-18 years from the Korean National Health and Nutrition examination survey, 1998 and 2001. Am J Epidemiol. 2006;164:787–793
  3. Ng VW, Kong AP, Choi KC, Ozaki R, Wong GW, So WY, et al. BMI and waist circumference in predicting cardiovascular risk factor clustering in Chinese adolescents. Obesity. 2007;15:494–503
  4. Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature. 2006;444:875–880
  5. Gunnell DJ, Frankel SJ, Nanchahal K, Peters TJ, Davey Smith G. Childhood obesity and adult cardiovascular mortality: a 57-y follow-up study based on the Boyd Orr cohort. Am J Clin Nutr. 1998;67:1111–1118
  6. Reinehr T, Andler W, Denzer C, Siegried W, Mayer H, Wabitsch M. Cardiovascular risk factors in overweight German children and adolescents: relation to gender, age and degree of overweight. Nutr Metab Cardiovasc Dis. 2005;15:181–187
  7. Styne DM. Childhood and adolescent obesity. Prevalence and significance. Pediatr Clin North Am. 2001;48:823–854
  8. Waring W, Esmail S. How should serum uric acid concentrations be interpreted in patients with hypertension?. Curr Hypertension Rev. 2005;1:89–95
  9. Kawada T, Otsuka T, Katsumata M, Suzuki H. Serum uric acid is significantly related to the components of the metabolic syndrome in Japanese workingmen. J Cardiometab Syndr. 2007;2:158–162
  10. Onat A, Uyarel H, Hergenc G, Karabulut A, Albayrak S, Sari I, et al. Serum uric acid as a determinant of metabolic syndrome in a population-based study. Am J Hypertens. 2006;19:1055–1062
  11. Strasak A, Ruttmann E, Brant L, Kelleher C, Klenk J, Concin H, et al. Serum uric acid and risk of cardiovascular mortality: a prospective long-term study of 83,683 Austrian men. Clin Chem. 2008;54:231–233
  12. Ishizaka N, Ishizaka Y, Toda E, Nagai R, Yamakado M. Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese individuals. Arteriscler Thromb Vasc Biol. 2005;25:1038–1044
  13. Takahashi S, Yamamoto T, Tsutsumi Z, Moriwaki Y, Yamakita J, Higashino K. Close correlation between visceral fat accumulation and uric acid metabolism in healthy men. Metabolism. 1997;46:1162–1165
  14. Tonstad S, Thorsrud H, Torjesen PA, Seljeflot I. Do novel risk factors differ between men and women aged 18 to 39 years with a high risk of coronary heart disease?. Metabolism. 2007;56:260–266
  15. Diamond FB, Cuthberston D, Hanna S, Eichler D. Correlates of adiponectin and the leptin/adiponectin ratio in obese and non-obese children. J Pediatr Endocrinol Metab. 2004;17:1069–1075
  16. Inoue M, Yano M, Yamakado M, Maehata E, Suzuki S. Relationship between the adiponectin–leptin ratio and parameters of insulin resistance in subjects without hyperglycemia. Metabolism. 2006;55:1248–1254
  17. Koebnick C, Shaibi GQ, Kelly LA, Roberts CK, Lane CJ, Toledo-Corral C, et al. Leptin-to-adiponectin ratio as independent predictor of insulin sensitivity during growth in overweight Hispanic youth. J Endocrinol Invest. 2007;30:RC13–RC16
  18. Frühbeck G. The adipose tissue as a source of vasoactive factors. Curr Med Chem Cardiovasc Hematol Agents. 2004;2:197–208
  19. Frühbeck G, Nutr R, Salvador J. Role of adipocytokines in metabolism and disease. Nutr Res. 2004;24:803–826
  20. Nishida M, Funahashi T, Shimomura I. Pathophysiological significance of adiponectin. Med Mol Morphol. 2007;40:55–67
  21. Satoh N, Naruse M, Usui T, Tagami T, Suganami T, Yamada K, et al. Leptin-to-adiponectin ratio as a potential atherogenic index in obese type 2 diabetic patients. Diabetes Care. 2004;27:2488–2490
  22. Yang R, Barouch L. Leptin signaling and obesity: cardiovascular consequences. Circ Res. 2007;101:545–559
  23. Singhal A, Farooqi IS, Cole TJ, O’Rahilly S, Fewtrell M, Kattenhorn M, et al. Influence of leptin on arterial distensibility: a novel link between obesity and cardiovascular disease?. Circulation. 2002;106:1904–1905
  24. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA. 2004;291:1730–1737
  25. Bacha F, Saad R, Gungor N, Arslanian S. Adiponectin in youth. Relationship to visceral adiposity, insulin sensitivity and beta-cell function. Diabetes Care. 2004;27:547–552
  26. Pilz S, Horejisi R, Moller R, Almer G, Scharnagl H, Stojakovic T, et al. Early atherosclerosis in obese juveniles is associated with low serum levels of adiponectin. J Clin Endocrinol Metab. 2005;90:4792–4796
  27. Beauloye V, Zech F, Mong H, Clapuyt P, Maes M, Brichard S. Determinants of early atherosclerosis in obese children and adolescents. J Clin Endocrionol Metab. 2007;92:3025–3032
  28. Kotani K, Sakane N, Saiga K, Kurozawa Y. Leptin:adiponectin ratio as an atherosclerotic index in patients with type 2 diabetes: relationship to the index of intima-media thickness. Diabetologia. 2005;48:2684–2686
  29. Oda N, Imamura S, Fujita T, Uchida Y, Inagaki K, Kakizawa H, et al. The ratio of leptin to adiponectin can be used as an index of insulin resistance. Metabolism. 2008;57:268–273
  30. Xita N, Papassotiriou I, Georgiou I, Vounatsou M, Margeli A, Tsatsoulis A. The adiponectin-to-leptin ratio in women with polycystic ovary syndrome: relation to insulin resistance and proinflammatory markers. Metabolism. 2007;56:766–771
  31. Galluccio E, Piatti P, Citterio L, Lucotti PC, Setola E, Cassina L, et al. Hyperinsulinemia and impaired leptin–adiponectin ratio associate with endothelial nitric oxide synthase polymorphisms in subjects with in-stent restenosis. Am J Physiol Endocrinol Metab. 2008;294(5):E978–E986
  32. Norata GD, Raselli S, Grigore L, Garlaschelli K, Dozio E, Magni P, et al. Leptin:adiponectin ratio is an independent predictor of intima media thickness of the common carotid artery. Stroke. 2007;38:2844–2846
  33. Letho S, Niskanen L, Ronnemaa T, Laakso M. Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus. Stroke. 1998;29:635–639
  34. Alderman MH, Cohen H, Madhavan S, Kivlighn S. Serum uric acid and cardiovascular events in successfully treated hypertensive patients. Hypertension. 1999;34:144–150
  35. Nakanishi N, Okamoto M, Yoshida H, Matsuo Y, Suzuki K, Tatara K. Serum uric acid and risk for development of hypertension and impaired fasting glucose or Type II diabetes in Japanese male office workers. Eur J Epidemiol. 2003;18:523–530
  36. Masuo K, Kawaguchi H, Mikami H, Ogihara T, Tuck ML. Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension. 2003;42:474–480
  37. Inoue T, Matsuoka M, Nagahama K, Iseki C, Touma T, Iseki K, et al. Cardiovascular risk factors associated with pulse pressure in a screened cohort in Okinawa, Japan. Hypertens Res. 2003;26:153–158
  38. Strasak AM, Kelleher CC, Brant LJ, Rapp K, Ruttmann E, Concin H, et al. Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28,613 elderly women: a prospective 21-year follow-up study. Int J Cardiol. 2008;125:232–239
  39. Lin JD, Chiou WK, Chang HY, Liu FH, Weng HF. Serum uric acid and leptin levels in metabolic syndrome: a quandary over the role of uric acid. Metabolism. 2007;56:751–756
  40. Denzer C, Muche R, Mayer H, Heinze E, Debatin KM, Wabitsch M. Serum uric acid levels in obese children and adolescents: linkage to testosterone levels and pre-metabolic syndrome. J Pediatr Endocrinol Metab. 2003;16:1225–1232
  41. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res. 2000;87:840–844
  42. Maxwell AJ, Bruinsma KA. Uric acid is closely linked to vascular nitric oxide activity. Evidence for mechanisms of association with cardiovascular disease. J Am Coll Cardiol. 2001;38:1850–1858
  43. Mahley RW, Arslan P, Pekcan G, Pépin GM, Ağaçdiken A, Karaağoğlu N, et al. Plasma lipids in Turkish children: impact of puberty, socioeconomic status, and nutrition on plasma cholesterol and HDL. J Lipid Res. 2001;42:1996–2006
  44. Herbst KL, Amory JK, Brunzell JD, Chansky HA, Bremner WJ. Testosterone administration to men increases hepatic lipase activity and decreases HDL and LDL size in 3 wk. Am J Physiol Endocrinol Metab. 2003;284:E1112–E1118
  45. Morrison JA, Barton BA, Biro FM, Sprecher DL. Sex hormones and the changes in adolescent male lipids: longitudinal studies in a biracial cohort. J. Pediatr. 2003;142:637–642

PII: S1875-6867(08)00204-2

doi: 10.1016/j.jomh.2008.09.010

journal of men's health
Volume 6, Issue 1 , Pages 63-69 , March 2009

Article Tools